Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Tytuł pozycji:

Prognostic Role of Mismatch Repair Status, Histotype and High-Risk Pathologic Features in Stage II Small Bowel Adenocarcinomas.

Tytuł :
Prognostic Role of Mismatch Repair Status, Histotype and High-Risk Pathologic Features in Stage II Small Bowel Adenocarcinomas.
Autorzy :
Vanoli A; Anatomic Pathology Unit, Department of Molecular Medicine, University of Pavia and Fondazione IRCCS San Matteo Hospital, Pavia, Italy. .
Grillo F; Pathology Unit, Department of Surgical and Diagnostic Sciences, University of Genoa and Ospedale Policlinico San Martino University Hospital, Genoa, Italy.
Guerini C; Anatomic Pathology Unit, Department of Molecular Medicine, University of Pavia and Fondazione IRCCS San Matteo Hospital, Pavia, Italy.
Neri G; Anatomic Pathology Unit, Department of Molecular Medicine, University of Pavia and Fondazione IRCCS San Matteo Hospital, Pavia, Italy.
Arpa G; Anatomic Pathology Unit, Department of Molecular Medicine, University of Pavia and Fondazione IRCCS San Matteo Hospital, Pavia, Italy.
Klersy C; Clinical Epidemiology and Biometry Unit, Fondazione IRCCS San Matteo Hospital, Pavia, Italy.
Nesi G; Division of Pathological Anatomy, Department of Surgery and Translational Medicine, University of Florence, Florence, Italy.
Giuffrida P; Department of Internal Medicine, University of Pavia and Fondazione IRCCS San Matteo Hospital, Pavia, Italy.
Sampietro G; Unit of General Surgery, ASST Rhodense, Rho Hospital, University of Milan, Milan, Italy.
Ardizzone S; Gastroenterology Unit, Luigi Sacco University Hospital, Milan, Italy.
Fociani P; Anatomic Pathology Unit, ASST Ovest Milanese, Milan, Italy.
Fiocca R; Pathology Unit, Department of Surgical and Diagnostic Sciences, University of Genoa and Ospedale Policlinico San Martino University Hospital, Genoa, Italy.
Latella G; Gastroenterology Unit, Department of Life and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
Sessa F; Pathology Unit, Department of Medicine and Surgery, University of Insubria, Varese, Italy.
D'Errico A; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), Institute of Oncology and Transplant Pathology, St. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
Malvi D; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), Institute of Oncology and Transplant Pathology, St. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
Mescoli C; Pathology Unit, Department of Medicine, University of Padua, Padua, Italy.
Rugge M; Pathology Unit, Department of Medicine, University of Padua, Padua, Italy.
Ferrero S; Division of Pathology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.
Poggioli G; Surgery of the Alimentary Tract, Department of Medical and Surgical Sciences, Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
Rizzello F; Intestinal Chronic Bowel Disease Unit, Department of Medical and Surgical Sciences, Sant'Orsola-Malpighi Hospital, Alma Mater Studiorum University of Bologna, Bologna, Italy.
Macciomei MC; Pathology Unit, San Camillo-Forlanini Hospital, Rome, Italy.
Santini D; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), Institute of Oncology and Transplant Pathology, St. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
Volta U; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
De Giorgio R; Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Italy.
Caio G; Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Italy.
Calabrò A; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy.
Ciacci C; Department of Medicine and Surgery, University of Salerno, Salerno, Italy.
D'Armiento M; Public Health Department, Federico II University of Naples, Naples, Italy.
Rizzo A; Unit of Pathology, Cervello Hospital, Palermo, Italy.
Solina G; Units of General Surgery, Cervello Hospital, Palermo, Italy.
Martino M; Department of Internal Medicine, University of Pavia and Fondazione IRCCS San Matteo Hospital, Pavia, Italy.
Tonelli F; Surgery and Translational Medicine, University of Florence, Florence, Italy.
Villanacci V; Institute of Pathology, Spedali Civili Hospital, Brescia, Italy.
Cannizzaro R; Department of Gastroenterology, Centro di Riferimento Oncologico (CRO) di Aviano IRCCS, Aviano, Italy.
Canzonieri V; Pathology Unit, Centro di Riferimento Oncologico (CRO) di Aviano IRCCS, Aviano, Italy.; Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.
Florena AM; Pathologic Anatomy Unit, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy.
Biancone L; Department of Systems Medicine, University of Tor Vergata, Rome, Italy.
Monteleone G; Department of Systems Medicine, University of Tor Vergata, Rome, Italy.
Caronna R; Department of Surgical Sciences, La Sapienza University, Rome, Italy.
Ciardi A; Department of Radiological, Oncological, Pathological Sciences, Umberto I Hospital, La Sapienza University, Rome, Italy.
Elli L; Gastroenterology and Endoscopy Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Caprioli F; Gastroenterology and Endoscopy Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Vecchi M; Gastroenterology and Endoscopy Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
D'Incà R; Gastroenterology Section, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.
Zingone F; Gastroenterology Section, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.
D'Odorico A; Gastroenterology Section, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.
Lenti MV; Department of Internal Medicine, University of Pavia and Fondazione IRCCS San Matteo Hospital, Pavia, Italy.
Oreggia B; General Surgery Unit, Ca' Granda-Ospedale Maggiore Policlinico, Milan, Italy.
Reggiani Bonetti L; Section of Pathology, Department of Diagnostic Medicine and Public Health, University of Modena and Reggio Emilia, Modena, Italy.
Giannone AG; Pathologic Anatomy Unit, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy.
Orlandi A; Department of Biopathology and Image Diagnostics, University of Tor Vergata, Rome, Italy.
Barresi V; Section of Anatomical Pathology, Department of Diagnostics and Public Health, University and Hospital Trust of Verona, Verona, Italy.
Ciccocioppo R; Gastroenterology Unit, Department of Medicine, AOUI Policlinico G.B. Rossi, University of Verona, Verona, Italy.
Amodeo G; Gastroenterology Unit, Department of Medicine, AOUI Policlinico G.B. Rossi, University of Verona, Verona, Italy.
Biletta E; Anatomic Pathology ASL Biella, Biella, Italy.
Luinetti O; Anatomic Pathology Unit, Department of Molecular Medicine, University of Pavia and Fondazione IRCCS San Matteo Hospital, Pavia, Italy.
Pedrazzoli P; Department of Internal Medicine, University of Pavia and Fondazione IRCCS San Matteo Hospital, Pavia, Italy.; Oncology Unit, IRCCS San Matteo Hospital, Pavia, Italy.
Pietrabissa A; Department of Surgery, General Surgery II, University of Pavia and Fondazione IRCCS San Matteo Hospital, Pavia, Italy.
Corazza GR; Department of Internal Medicine, University of Pavia and Fondazione IRCCS San Matteo Hospital, Pavia, Italy.
Solcia E; Anatomic Pathology Unit, Department of Molecular Medicine, University of Pavia and Fondazione IRCCS San Matteo Hospital, Pavia, Italy.
Paulli M; Anatomic Pathology Unit, Department of Molecular Medicine, University of Pavia and Fondazione IRCCS San Matteo Hospital, Pavia, Italy.
Di Sabatino A; Department of Internal Medicine, University of Pavia and Fondazione IRCCS San Matteo Hospital, Pavia, Italy.
Pokaż więcej
Źródło :
Annals of surgical oncology [Ann Surg Oncol] 2021 Feb; Vol. 28 (2), pp. 1167-1177. Date of Electronic Publication: 2020 Aug 05.
Typ publikacji :
Journal Article
Język :
English
Imprint Name(s) :
Publication: 2005- : New York, NY : Springer
Original Publication: New York, NY : Raven Press, c1994-
MeSH Terms :
Adenocarcinoma*/genetics
Colorectal Neoplasms*
DNA Mismatch Repair/genetics ; Female ; Humans ; Male ; Microsatellite Instability ; Mismatch Repair Endonuclease PMS2/genetics ; Mismatch Repair Endonuclease PMS2/metabolism ; MutL Protein Homolog 1/genetics ; MutL Protein Homolog 1/metabolism ; MutS Homolog 2 Protein/genetics ; MutS Homolog 2 Protein/metabolism ; Prognosis
References :
Clin Colorectal Cancer. 2019 Sep;18(3):218-225. (PMID: 31178274)
J Crohns Colitis. 2020 Mar 13;14(3):295-302. (PMID: 31418007)
BMC Gastroenterol. 2019 Mar 27;19(1):45. (PMID: 30917787)
Mod Pathol. 2017 Oct;30(10):1453-1466. (PMID: 28664941)
Hum Pathol. 2019 Mar;85:18-26. (PMID: 30381262)
Dig Liver Dis. 2018 Jan;50(1):15-19. (PMID: 29174568)
Ann Surg Oncol. 2012 May;19(5):1439-45. (PMID: 22187121)
J Natl Compr Canc Netw. 2019 Sep 1;17(9):1135-1141. (PMID: 31487680)
Surgery. 2015 Aug;158(2):486-93. (PMID: 26013988)
Mod Pathol. 2020 Jul;33(7):1398-1409. (PMID: 32066859)
Clin Colorectal Cancer. 2017 Sep;16(3):220-227. (PMID: 27670893)
Br J Cancer. 2010 Jan 5;102(1):144-50. (PMID: 19935793)
Am J Clin Pathol. 2017 Sep 1;148(3):208-214. (PMID: 28821192)
J Crohns Colitis. 2017 Aug 1;11(8):942-953. (PMID: 28333239)
Clin Cancer Res. 2014 Oct 15;20(20):5322-30. (PMID: 25139339)
Nat Rev Clin Oncol. 2013 Sep;10(9):534-44. (PMID: 23897080)
Cancer Res. 2004 Oct 1;64(19):7073-7. (PMID: 15466202)
Br J Cancer. 2013 Dec 10;109(12):3057-66. (PMID: 24196786)
Clin Colorectal Cancer. 2019 Dec;18(4):257-268. (PMID: 31606297)
J Clin Oncol. 2009 Nov 1;27(31):5131-7. (PMID: 19738119)
PLoS One. 2018 Aug 10;13(8):e0200204. (PMID: 30096150)
J Crohns Colitis. 2017 Jan;11(1):3-25. (PMID: 27660341)
Virchows Arch. 2017 Oct;471(4):549-552. (PMID: 28752215)
Lancet. 2009 Apr 25;373(9673):1480-93. (PMID: 19394538)
J Natl Compr Canc Netw. 2019 Sep 1;17(9):1109-1133. (PMID: 31487687)
Mod Pathol. 2017 Feb;30(2):255-266. (PMID: 27739441)
PLoS Genet. 2018 Mar 9;14(3):e1007200. (PMID: 29522538)
Cancer. 2010 Dec 1;116(23):5374-82. (PMID: 20715162)
J Surg Oncol. 2003 Nov;84(3):127-31. (PMID: 14598355)
J Gastrointest Surg. 2016 Feb;20(2):401-10. (PMID: 26487334)
Arch Pathol Lab Med. 2000 Jul;124(7):979-94. (PMID: 10888773)
Cancer. 2016 Mar 1;122(5):693-701. (PMID: 26717303)
Grant Information :
Ministero Italiano della Salute Fondazione IRCCS Policlinico San Matteo
Substance Nomenclature :
EC 3.6.1.3 (Mismatch Repair Endonuclease PMS2)
EC 3.6.1.3 (MutL Protein Homolog 1)
EC 3.6.1.3 (MutS Homolog 2 Protein)
Entry Date(s) :
Date Created: 20200808 Date Completed: 20210427 Latest Revision: 20210427
Update Code :
20210428
PubMed Central ID :
PMC7801310
DOI :
10.1245/s10434-020-08926-4
PMID :
32761330
Czasopismo naukowe
Background: Small bowel adenocarcinoma is a relatively rare cancer, often diagnosed in an advanced stage. In localized and resectable disease, surgery alone or in combination with adjuvant chemotherapy is the mainstay of treatment. In the recently published National Comprehensive Cancer Network Clinical Practice guidelines, criteria for selecting patients with stage II small bowel adenocarcinoma to receive adjuvant chemotherapy are provided, and they are mainly extrapolated from studies on colorectal cancer.
Patients and Methods: In the present study, we aimed to verify whether mismatch repair deficiency phenotype, high-risk pathologic features (including T4, positive resection margins and a low number of lymph nodes harvested), as well as tumor histologic subtype, were associated with cancer-specific survival in 66 stage II non-ampullary small bowel adenocarcinoma patients, collected through the Small Bowel Cancer Italian Consortium. A central histopathology review was performed. Mismatch repair deficiency was tested by immunohistochemistry for MLH1, MSH2, MSH6 and PMS2, and confirmed by polymerase chain reaction for microsatellite instability.
Results: We identified mismatch repair deficiency, glandular/medullary histologic subtype, and celiac disease as significant predictors of favorable cancer-specific survival using univariable analysis with retained significance in bivariable models adjusted for pT stage. Among the high-risk features, only T4 showed a significant association with an increased risk of death; however, its prognostic value was not independent of mismatch repair status.
Conclusions: Mismatch repair protein expression, histologic subtype, association with celiac disease, and, in the mismatch repair proficient subset only, T stage, may help identify patients who may benefit from adjuvant chemotherapy.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies